Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

The function of CLN3P, the Batten disease protein.

Rakheja D, Narayan SB, Bennett MJ.

Mol Genet Metab. 2008 Mar;93(3):269-74. Review. No abstract available. Erratum in: Mol Genet Metab. 2008 Jun;94(2):270.

PMID:
18688960
[PubMed - indexed for MEDLINE]
2.

CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.

Narayan SB, Pastor JV, Mitchison HM, Bennett MJ.

Brain. 2004 Aug;127(Pt 8):1748-54. Epub 2004 Jul 7.

PMID:
15240430
[PubMed - indexed for MEDLINE]
Free Article
3.

CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.

Rusyn E, Mousallem T, Persaud-Sawin DA, Miller S, Boustany RM.

Pediatr Res. 2008 Jun;63(6):625-31. doi: 10.1203/PDR.0b013e31816fdc17.

PMID:
18317235
[PubMed - indexed for MEDLINE]
4.

CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes).

Rakheja D, Narayan SB, Pastor JV, Bennett MJ.

Biochem Biophys Res Commun. 2004 May 14;317(4):988-91.

PMID:
15094366
[PubMed - indexed for MEDLINE]
5.

A model for Batten disease protein CLN3: functional implications from homology and mutations.

Janes RW, Munroe PB, Mitchison HM, Gardiner RM, Mole SE, Wallace BA.

FEBS Lett. 1996 Dec 9;399(1-2):75-7.

PMID:
8980123
[PubMed - indexed for MEDLINE]
6.

Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).

Leman AR, Pearce DA, Rothberg PG.

Hum Genet. 2005 May;116(6):544. No abstract available.

PMID:
15991331
[PubMed - indexed for MEDLINE]
7.

Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).

Leman AR, Pearce DA, Rothberg PG.

Hum Genet. 2005 Feb;116(3):236. No abstract available.

PMID:
15818814
[PubMed - indexed for MEDLINE]
8.

Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: further evidence that CLN3P has anti-apoptotic properties.

Narayan SB, Rakheja D, Pastor JV, Rosenblatt K, Greene SR, Yang J, Wolf BA, Bennett MJ.

Mol Genet Metab. 2006 Jun;88(2):178-83. Epub 2006 Mar 3.

PMID:
16515873
[PubMed - indexed for MEDLINE]
9.

Experimental models of NCL: the yeast model.

Pearce DA.

Adv Genet. 2001;45:205-16. Review. No abstract available.

PMID:
11332774
[PubMed - indexed for MEDLINE]
10.

Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.

Rakheja D, Narayan SB, Bennett MJ.

Curr Mol Med. 2007 Sep;7(6):603-8. Review.

PMID:
17896996
[PubMed - indexed for MEDLINE]
11.

A yeast model for the study of Batten disease.

Pearce DA, Sherman F.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6915-8.

PMID:
9618513
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease.

Croopnick JB, Choi HC, Mueller DM.

Biochem Biophys Res Commun. 1998 Sep 18;250(2):335-41.

PMID:
9753630
[PubMed - indexed for MEDLINE]
13.

Deletion of btn1, an orthologue of CLN3, increases glycolysis and perturbs amino acid metabolism in the fission yeast model of Batten disease.

Pears MR, Codlin S, Haines RL, White IJ, Mortishire-Smith RJ, Mole SE, Griffin JL.

Mol Biosyst. 2010 Jun;6(6):1093-102. doi: 10.1039/b915670d. Epub 2010 Mar 17.

PMID:
20485751
[PubMed - indexed for MEDLINE]
14.

Characterization of Cln3p, the gene product responsible for juvenile neuronal ceroid lipofuscinosis, as a lysosomal integral membrane glycoprotein.

Ezaki J, Takeda-Ezaki M, Koike M, Ohsawa Y, Taka H, Mineki R, Murayama K, Uchiyama Y, Ueno T, Kominami E.

J Neurochem. 2003 Dec;87(5):1296-308.

PMID:
14622109
[PubMed - indexed for MEDLINE]
15.

Intermediate levels of neuronal palmitoyl-protein Delta-9 desaturase in heterozygotes for murine Batten disease.

Narayan SB, Tan L, Bennett MJ.

Mol Genet Metab. 2008 Jan;93(1):89-91. Epub 2007 Oct 24.

PMID:
17962056
[PubMed - indexed for MEDLINE]
16.

Defective lysosomal arginine transport in juvenile Batten disease.

Ramirez-Montealegre D, Pearce DA.

Hum Mol Genet. 2005 Dec 1;14(23):3759-73. Epub 2005 Oct 26.

PMID:
16251196
[PubMed - indexed for MEDLINE]
Free Article
17.

Investigation of Batten disease with the yeast Saccharomyces cerevisiae.

Pearce DA, Sherman F.

Mol Genet Metab. 1999 Apr;66(4):314-9.

PMID:
10191120
[PubMed - indexed for MEDLINE]
18.

Altered gene expression in the eye of a mouse model for batten disease.

Chattopadhyay S, Kingsley E, Serour A, Curran TM, Brooks AI, Pearce DA.

Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2893-905.

PMID:
15326100
[PubMed - indexed for MEDLINE]
Free Article
19.

CLN3P, the Batten's disease protein, is a novel palmitoyl-protein Delta-9 desaturase.

Narayan SB, Rakheja D, Tan L, Pastor JV, Bennett MJ.

Ann Neurol. 2006 Nov;60(5):570-7.

PMID:
17036287
[PubMed - indexed for MEDLINE]
20.

A novel role of the Batten disease gene CLN3: association with BMP synthesis.

Hobert JA, Dawson G.

Biochem Biophys Res Commun. 2007 Jun 22;358(1):111-6. Epub 2007 Apr 19.

PMID:
17482562
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk